Market Place
Sourcing Support
Medolife Rx Schedules Conference Call with Investment Community
04 May 2022 //
GLOBENEWSWIRE
Medolife Rx Announces Changes to Management and Improvements to AELIA
07 Feb 2022 //
GLOBENEWSWIRE
Medolife Rx Presents Its Venom-To-Drug Development Projects
11 Jan 2022 //
GLOBENEWSWIRE
Medolife Rx Schedules Conference Call with Investment Community
19 Nov 2021 //
GLOBENEWSWIRE
Medolife Rx Reports 257% Increase in Efficacy of Ibuprofen
12 Oct 2021 //
GLOBENEWSWIRE
Medolife Rx Initiates Comparative Study of Its Flagship CBD-based Muscle
06 Oct 2021 //
GLOBENEWSWIRE
Medolife Rx Recaps Successful Attendance at Tony Hawk Event
01 Sep 2021 //
GLOBENEWSWIRE
Medolife Rx Launches Pharmacokinetic Study on Lead Drug Candidate
03 Aug 2021 //
YAHOO
Medolife Rx Cancels Optional Reverse Split Previously Included in Filing
29 Jul 2021 //
GLOBENEWSWIRE
Medolife Rx Schedules Investor Webcast for Tuesday, July 27, 2021
21 Jul 2021 //
GLOBENEWSWIRE
Medolife Rx Announces Donation of Escozine to Heath Clinic
14 Jul 2021 //
GLOBENEWSWIRE
Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine
08 Jul 2021 //
GLOBENEWSWIRE
Medolife Announces Successful Stability Results on Escozine Conjugated
01 Jul 2021 //
GLOBENEWSWIRE
Medolife Rx Enters Partnership Agreement with Leading International Distributor
29 Jun 2021 //
GLOBENEWSWIRE
Medolife Rx Announces PreClinical Results on Escozine Showing Synergistic Effect
20 Apr 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.